Susceptibility of Lung Carcinoma Cells to Nanostructured Lipid Carrier of ARV-825, a BRD4 Degrading Proteolysis Targeting Chimera
Crossref DOI link: https://doi.org/10.1007/s11095-022-03184-3
Published Online: 2022-02-10
Published Print: 2022-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vartak, Richa
Saraswat, Aishwarya
Yang, Yuqi
Chen, Zhe-Sheng
Patel, Ketan
Text and Data Mining valid from 2022-02-10
Version of Record valid from 2022-02-10
Article History
Received: 28 October 2021
Accepted: 31 January 2022
First Online: 10 February 2022
Conflicts of Interests
: No conflict of interest.